Well Health - Digitale Services für die Medizin (Seite 3)
eröffnet am 12.11.22 11:39:23 von
neuester Beitrag 01.05.24 12:37:21 von
neuester Beitrag 01.05.24 12:37:21 von
Beiträge: 99
ID: 1.364.777
ID: 1.364.777
Aufrufe heute: 11
Gesamt: 8.196
Gesamt: 8.196
Aktive User: 0
ISIN: CA94947L1022 · WKN: A2JQV6 · Symbol: WELL
3,6100
CAD
-1,10 %
-0,0400 CAD
Letzter Kurs 01.05.24 Toronto
Neuigkeiten
21.03.24 · IRW Press |
30.11.23 · IRW Press |
14.11.23 · IRW Press |
Werte aus der Branche Finanzdienstleistungen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,4000 | +28,30 | |
| 32,00 | +27,95 | |
| 1,5400 | +26,23 | |
| 12,700 | +19,81 | |
| 6,3000 | +14,55 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 5,1500 | -11,21 | |
| 0,7000 | -11,84 | |
| 14,750 | -14,14 | |
| 1,8775 | -14,17 | |
| 1,1500 | -20,14 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 75.341.768 von Chash-Carry am 25.02.24 17:06:47Frag am besten w:o z.Th. Thread ...
Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care
Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’ that can help them improve diagnosis of rare and chronic diseases, improve efficiency of their practice, and improve patient health outcomes.
WELL is currently the largest shareholder of HEALWELL with ownership of 20.7% of the company’s issued and outstanding voting securities. WELL also has an option to acquire approximately 30 million multi-voting shares that would give WELL a controlling position in HEALWELL, as defined on an IFRS financial reporting basis.
...
https://www.globenewswire.com/news-release/2024/02/27/283570…
Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care
Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’ that can help them improve diagnosis of rare and chronic diseases, improve efficiency of their practice, and improve patient health outcomes.
WELL is currently the largest shareholder of HEALWELL with ownership of 20.7% of the company’s issued and outstanding voting securities. WELL also has an option to acquire approximately 30 million multi-voting shares that would give WELL a controlling position in HEALWELL, as defined on an IFRS financial reporting basis.
...
https://www.globenewswire.com/news-release/2024/02/27/283570…
Zitat von Chash-Carry: Moin der Investoren Kreis bei Well ist ja hier überschaubar. Was mich interessieren würde ist ob einer von euch bei Well AI investiert ist und was ihr von dem Ableger haltet? Was mich noch interessiert ist warum kann man bei WO kein Forum für Well AI eröffnen?? Wenn mir da jemand helfen könnte wäre ich dankbar. 😀 schönes Wochenende
Moin der Investoren Kreis bei Well ist ja hier überschaubar. Was mich interessieren würde ist ob einer von euch bei Well AI investiert ist und was ihr von dem Ableger haltet? Was mich noch interessiert ist warum kann man bei WO kein Forum für Well AI eröffnen?? Wenn mir da jemand helfen könnte wäre ich dankbar. 😀 schönes Wochenende
WELL Health wird "missverstanden" und ist unterbewertet, sagt RBC
Am 6. Februar begann Douglas Miehm, Analyst bei RBC Capital Markets, die Coverage von WELL mit einem "Outperform"-Rating und einem Kursziel von 5,50 US-Dollar, was zum Zeitpunkt der Veröffentlichung eine Rendite von 50 Prozent impliziert.Der Analyst sagte, er denke, dass es derzeit eine Chance für Investoren gebe, da WELL Health "weitgehend missverstanden" werde.
"Wir starten bei WELL Health mit einem Outperform-Rating und einem Kursziel von 5,50 $", sagte Miehm. "Wir sehen WELL als ein komplexes, weitgehend missverstandenes Unternehmen und glauben, dass der Markt die langfristige wertschöpfende Chance bei der Transformation der CDN-Primär-/Dx-Versorgung unterschätzt, wie unsere starken prognostizierten ROIC- und IRR-Kennzahlen für die jüngsten Akquisitionen unterstreichen. In den USA sollte WELL von den Geschäftsbereichen mit hohem organischem Wachstum (20%+), Circle and Wisp und CRH mit hohen Margen profitieren. Da die Anleger beginnen, die potenziellen Chancen zu nutzen, die sich WELL bieten, glauben wir, dass die Aktie zulegen und die Konkurrenz übertreffen wird."
...
https://www.cantechletter.com/2024/02/well-health-is-misunde…
RBC Capital starts coverage on Well Health Technologies with Outperform rating
On Tuesday, RBC (TSX:RY) Capital initiated coverage on Well Health Technologies Corp. (WELL:CN) (OTC: WLYYF), assigning an Outperform rating with a price target of C$5.50. The firm recognizes Well Health as a multifaceted entity that is not fully understood by the market, suggesting that its long-term potential in transforming Canadian primary and diagnostic care is not fully appreciated.According to RBC Capital, the company's recent acquisitions are expected to yield strong returns on invested capital (ROIC) and internal rates of return (IRR), indicating a positive outlook for the company's growth. The firm's analysis points to Well Health's opportunity to create value in a sector that is poised for transformation.
...
https://ca.investing.com/news/stock-market-news/rbc-capital-…
WELL Health Announces Record Patient Visits and Total Care Interactions for Q4-2023 and Projects Record Revenue and Positive EPS for the Quarter
WELL expects to announce positive EPS or Earnings Per Share on an adjusted and unadjusted basis for Q4-2023.1
WELL expects to announce its 20th consecutive quarter of record quarterly revenue in Q4-2023, underpinned by record care metrics which includes record patient visits of over 1.22 million and almost 1.87 million Total Care Interactions in the quarter with both metrics representing 18% sequential QoQ growth.2,3
This quarter's strong performance was driven by double-digit YoY organic growth as well as elevated inorganic growth in both US and Canadian patient visits. On a YoY basis, overall patient visits grew by 30% while Total Care Interactions grew by 38%.
WELL is proud to announce that its BC clinics which include some of the longest owned and operated clinics in the WELL family network have achieved a record Net Promoter Score (NPS) of 80% in Q4-2023 compared to industry average of 34% for the Canadian healthcare sector.4,5
VANCOUVER, BC and TORONTO, Jan. 25, 2024 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) ("WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce positive preliminary quarterly financial results for Q4-2023 ending December 31, 2023 with projected record revenue and positive adjusted and non-adjusted EPS or Earnings per Share.1 WELL's strong financial performance was driven by another record quarter in patient visits which resulted in sequential QoQ growth of 18% and YoY growth of 30%.2
Hamed Shahbazi, Founder and CEO of WELL, commented "Based on our preliminary financial results and subject to finalizing our audit, I am extremely pleased to report that WELL expects to announce record revenues and Adjusted EBITDA including positive adjusted and unadjusted EPS for Q4 2023. As discussed in our business update last week, WELL's value proposition is resonating with the medical community across the country as the clear leader in helping clinic owners, administrators and care providers improve clinic operations. This is not only attracting an unprecedented number of new clinics and healthcare providers to WELL, but it is also giving us an opportunity to grow in an extremely capital efficient manner. Most of the clinics we add to our platform are profitable on day one and are handpicked because of the opportunity for margin and profit expansion. All of this is made possible due to our talented staff, extensive operating experience, and trusted technology platform now features powerful and responsible use of Artificial Intelligence."
...
https://www.finanznachrichten.de/nachrichten-2024-01/6123082…
WELL expects to announce positive EPS or Earnings Per Share on an adjusted and unadjusted basis for Q4-2023.1
WELL expects to announce its 20th consecutive quarter of record quarterly revenue in Q4-2023, underpinned by record care metrics which includes record patient visits of over 1.22 million and almost 1.87 million Total Care Interactions in the quarter with both metrics representing 18% sequential QoQ growth.2,3
This quarter's strong performance was driven by double-digit YoY organic growth as well as elevated inorganic growth in both US and Canadian patient visits. On a YoY basis, overall patient visits grew by 30% while Total Care Interactions grew by 38%.
WELL is proud to announce that its BC clinics which include some of the longest owned and operated clinics in the WELL family network have achieved a record Net Promoter Score (NPS) of 80% in Q4-2023 compared to industry average of 34% for the Canadian healthcare sector.4,5
VANCOUVER, BC and TORONTO, Jan. 25, 2024 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) ("WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce positive preliminary quarterly financial results for Q4-2023 ending December 31, 2023 with projected record revenue and positive adjusted and non-adjusted EPS or Earnings per Share.1 WELL's strong financial performance was driven by another record quarter in patient visits which resulted in sequential QoQ growth of 18% and YoY growth of 30%.2
Hamed Shahbazi, Founder and CEO of WELL, commented "Based on our preliminary financial results and subject to finalizing our audit, I am extremely pleased to report that WELL expects to announce record revenues and Adjusted EBITDA including positive adjusted and unadjusted EPS for Q4 2023. As discussed in our business update last week, WELL's value proposition is resonating with the medical community across the country as the clear leader in helping clinic owners, administrators and care providers improve clinic operations. This is not only attracting an unprecedented number of new clinics and healthcare providers to WELL, but it is also giving us an opportunity to grow in an extremely capital efficient manner. Most of the clinics we add to our platform are profitable on day one and are handpicked because of the opportunity for margin and profit expansion. All of this is made possible due to our talented staff, extensive operating experience, and trusted technology platform now features powerful and responsible use of Artificial Intelligence."
...
https://www.finanznachrichten.de/nachrichten-2024-01/6123082…
Trading Spotlight
Analystenmeinung
https://ca.finance.yahoo.com/news/3-reasons-buy-well-health-…Übersetzung:
WELL Health hat seinen Umsatz von 50,2 Millionen Dollar im Jahr 2020 auf 569 Millionen Dollar im Jahr 2023 erhöht, vor allem aufgrund hochgradiger Akquisitionen. Der Umsatz in den letzten 12 Monaten ist auf 700 Millionen Dollar gestiegen, und es wird prognostiziert, dass das Unternehmen den Umsatz um 33,8% auf 762 Millionen Dollar im Jahr 2023 und um 19 % auf 907 Millionen Dollar im Jahr 2024 steigern wird.
Darüber hinaus haben seine Akquisitionen es WELL Health ermöglicht, südlich der Grenze erhebliche Zugkraft zu gewinnen. In den letzten Jahren erwarb Well Health drei in den USA ansässige Gesundheitsunternehmen:
CRH: Es bietet spezialisierte Pflegedienstleistungen an, die sich darauf konzentrieren, Gastroenterologen in den USA ein Portfolio von Produkten und Lösungen zu bieten.
Circle Medical: Es ist ein Full-Cycle Primary Care Anbieter, der virtuelle und persönliche Versorgung anbietet, mit einer Spezialisierung auf Angebote im Zusammenhang mit der psychischen Gesundheit.
Wisp: Ein Online-Anbieter von Frauengesundheits- und E-Verschreibungsdiensten.
Während diese Akquisitionen ein Spitzenwachstum für WELL erbracht haben, steigerte das Unternehmen im dritten Quartal (Q3) auch den organischen Umsatz um 16 %, da es Rekordumsätze in Kanada und den USA meldete.
Verbesserung der Gewinnspannen
Ähnlich wie mehrere andere Wachstumsaktien hat WELL seine Gewinnspannen für das Umsatzwachstum geopfert. Aber in den letzten Monaten hat es sich auf die Verbesserung der Gewinnspannen und die Stärkung der Bilanz konzentriert.
Rekordpatientenbesuche im dritten Quartal ermöglichten es WELL Health, das bereinigte EBITDA (Gewinn vor Zinsen, Steuern, Abschreibungen und Amortisation) auf 28,2 Millionen Dollar zu erhöhen, gegenüber 27 Millionen Dollar im Vorjahreszeitraum.
Analysten, die die TSX-Aktie verfolgen, erwarten auch, dass ihr bereinigter Verlust pro Aktie von 0,14 $ im Jahr 2023 auf 0,07 $ im Jahr 2024 reduziert wird.
WELL-Aktien sind unterbewertet
Die WELL-Aktie kostet nur das 1,1-fache des Forward-Verkaufs und ist ziemlich billig und wird mit einem Rabatt auf Konsens-Preiszielschätzungen gehandelt. Analysten, die die TSX-Aktie verfolgen, erwarten, dass sie sich in den nächsten 12 Monaten mehr als verdoppeln und die breiteren Indizes leicht übertreiten.
Hoffe die 4 CAD fallen endlich
WELL Health Provides Business Update Demonstrating Focus on Profitable and Capital Efficient Growth
WELL's clinic recruitment, absorption and acquisition program has demonstrated substantial growth and capital efficiency having added two Canadian clinics in Q4-2023 generating approximately $28 million in annualized revenues for total consideration of less than $400,000 and are expected to positively contribute to EBITDA in 2024. WELL now operates 167 clinics in 98 facilities across Canada.
WELL has initiated an enterprise-wide cost optimization initiative, with a focus on improving cost efficiency and improving operating cashflow. It is expected that the Company will leverage a multitude of strategies including tech enablement, robotic process automation, and artificial intelligence for further cost optimization across its enterprise.
OceanMD continues its successful growth journey and has started its work with the PHSA in British Columbia . WELL continues to expect the full realization of the previously announced $38.5 million contract and is making progress on pursuing new public sector opportunities in its business development pipeline.
Hamed Shahbazi, Founder and CEO of WELL, commented, "2023 was a landmark year for WELL, marked by significant growth, record revenues and EBITDA but perhaps what encourages us the most is how doctors and clinic owners across the country are proactively approaching WELL for support on managing their clinics. This has caused an unprecedented growth in the inbound interest in our owned and operated patient care business leading to an acceleration in our organic growth. Simply put, our growth is no longer just limited to buying clinics or developing greenfield sites, we are now attracting and recruiting entire clinics with a full roster of patients and providers for nominal consideration. We refer to this as our clinic absorption program. This is because care providers are increasingly trusting WELL and looking to be 'absorbed' by WELL such that they be supported with professional management that allows them focus on delivering the best care possible."
...
https://www.finanznachrichten.de/nachrichten-2024-01/6114756…
WELL's clinic recruitment, absorption and acquisition program has demonstrated substantial growth and capital efficiency having added two Canadian clinics in Q4-2023 generating approximately $28 million in annualized revenues for total consideration of less than $400,000 and are expected to positively contribute to EBITDA in 2024. WELL now operates 167 clinics in 98 facilities across Canada.
WELL has initiated an enterprise-wide cost optimization initiative, with a focus on improving cost efficiency and improving operating cashflow. It is expected that the Company will leverage a multitude of strategies including tech enablement, robotic process automation, and artificial intelligence for further cost optimization across its enterprise.
OceanMD continues its successful growth journey and has started its work with the PHSA in British Columbia . WELL continues to expect the full realization of the previously announced $38.5 million contract and is making progress on pursuing new public sector opportunities in its business development pipeline.
Hamed Shahbazi, Founder and CEO of WELL, commented, "2023 was a landmark year for WELL, marked by significant growth, record revenues and EBITDA but perhaps what encourages us the most is how doctors and clinic owners across the country are proactively approaching WELL for support on managing their clinics. This has caused an unprecedented growth in the inbound interest in our owned and operated patient care business leading to an acceleration in our organic growth. Simply put, our growth is no longer just limited to buying clinics or developing greenfield sites, we are now attracting and recruiting entire clinics with a full roster of patients and providers for nominal consideration. We refer to this as our clinic absorption program. This is because care providers are increasingly trusting WELL and looking to be 'absorbed' by WELL such that they be supported with professional management that allows them focus on delivering the best care possible."
...
https://www.finanznachrichten.de/nachrichten-2024-01/6114756…
Antwort auf Beitrag Nr.: 75.009.548 von cbdexperte am 23.12.23 00:30:44
Weitere Infos zu doctorly
https://www.businessinsider.de/gruenderszene/health/doctorly…
Diese Nachricht aus der Well Health Investors Seite:
„WELL Ventures, investee doctorly GmbH, the only VC-backed startup in Germany authorized to sell practice management software, has attracted a new round of funding of €6.7M in Series A Extension. The Round was led by Dusseldorf based Simon Capital and included participation from Geschwister Oetker Beteiligungen KG, UNIQA Ventures and WELL’s investee HEALWELL AI (TSX: AIDX).“
hat mich dazu bewogen hier weiter nachzulegen und ich werde auch regelmäßig zukaufen.
Bei den aktuellen Unterbewertungen und den wiederkehrenden regelmäßigen Umsatzsteigerungen, sowie den Potentialen in der Digitalisierung der Medizin sehe ich diesen Wert als potenziellen Übernahmekandidat von BigPharma oder kommenden bluechip.
Keine Kaufempfehlung-nur meine persönliche Chance-Risiko Bewertung.
„WELL Ventures, investee doctorly GmbH, the only VC-backed startup in Germany authorized to sell practice management software, has attracted a new round of funding of €6.7M in Series A Extension. The Round was led by Dusseldorf based Simon Capital and included participation from Geschwister Oetker Beteiligungen KG, UNIQA Ventures and WELL’s investee HEALWELL AI (TSX: AIDX).“
hat mich dazu bewogen hier weiter nachzulegen und ich werde auch regelmäßig zukaufen.
Bei den aktuellen Unterbewertungen und den wiederkehrenden regelmäßigen Umsatzsteigerungen, sowie den Potentialen in der Digitalisierung der Medizin sehe ich diesen Wert als potenziellen Übernahmekandidat von BigPharma oder kommenden bluechip.
Keine Kaufempfehlung-nur meine persönliche Chance-Risiko Bewertung.
Durchsuchen
21.03.24 · IRW Press · WELL Health Technologies |
30.11.23 · IRW Press · WELL Health Technologies |
14.11.23 · IRW Press · CAD/USD |